Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Kaye

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
The American Journal of Pathology|August 1, 2009
SIGNR1-negative red pulp macrophages protect against acute streptococcal sepsis after Leishmania donovani-induced loss of marginal zone macrophagesAlun C Kirby, Lynette Beattie, Asher Maroof, et al.
Seminars in Immunopathology|March 11, 2020
Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugsPaul M Kaye, Israel Cruz, Albert Picado, et al.
Plos Neglected Tropical Diseases|September 21, 2021
Human leishmaniasis vaccines: Use cases, target population and potential global demandStefano Malvolti, Melissa Malhame, Carsten F Mantel, et al.
European Journal of Immunology|June 23, 2006
Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cellsSimona Stäger, Asher Maroof, Soombul Zubairi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Antigen-experienced T cells limit the priming of naive T cells during infection with Leishmania majorPeter M Gray, Steven L Reiner, Deborah F Smith, et al.
Blood Advances|March 12, 2021
Dissecting pathways to thrombocytopenia in a mouse model of visceral leishmaniasisGulab Fatima Rani, Olivier Preham, Helen Ashwin, et al.
The American Journal of Pathology|June 28, 2011
Compartment-specific remodeling of splenic micro-architecture during experimental visceral leishmaniasisPinar Yurdakul, Jane Dalton, Lynette Beattie, et al.
Vaccine|February 26, 2024
Neglected tropical disease vaccines: hookworm, leishmaniasis, and schistosomiasisPeter J Hotez, Maria Elena Bottazzi, Paul M Kaye, et al.
The Journal of Infectious Diseases|June 2, 2011
Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Rα-responsive macrophages and neutrophilsEmma McFarlane, Katharine C Carter, Andrew N McKenzie, et al.
Pathogens (Basel, Switzerland)|November 11, 2022
Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial DesignsMalcolm S Duthie, Bruna A S Machado, Roberto Badaró, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
The American Journal of Pathology|August 1, 2009
SIGNR1-negative red pulp macrophages protect against acute streptococcal sepsis after Leishmania donovani-induced loss of marginal zone macrophagesAlun C Kirby, Lynette Beattie, Asher Maroof, et al.
Seminars in Immunopathology|March 11, 2020
Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugsPaul M Kaye, Israel Cruz, Albert Picado, et al.
Plos Neglected Tropical Diseases|September 21, 2021
Human leishmaniasis vaccines: Use cases, target population and potential global demandStefano Malvolti, Melissa Malhame, Carsten F Mantel, et al.
European Journal of Immunology|June 23, 2006
Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cellsSimona Stäger, Asher Maroof, Soombul Zubairi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Antigen-experienced T cells limit the priming of naive T cells during infection with Leishmania majorPeter M Gray, Steven L Reiner, Deborah F Smith, et al.
Blood Advances|March 12, 2021
Dissecting pathways to thrombocytopenia in a mouse model of visceral leishmaniasisGulab Fatima Rani, Olivier Preham, Helen Ashwin, et al.
The American Journal of Pathology|June 28, 2011
Compartment-specific remodeling of splenic micro-architecture during experimental visceral leishmaniasisPinar Yurdakul, Jane Dalton, Lynette Beattie, et al.
Vaccine|February 26, 2024
Neglected tropical disease vaccines: hookworm, leishmaniasis, and schistosomiasisPeter J Hotez, Maria Elena Bottazzi, Paul M Kaye, et al.
The Journal of Infectious Diseases|June 2, 2011
Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Rα-responsive macrophages and neutrophilsEmma McFarlane, Katharine C Carter, Andrew N McKenzie, et al.
Pathogens (Basel, Switzerland)|November 11, 2022
Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial DesignsMalcolm S Duthie, Bruna A S Machado, Roberto Badaró, et al.
Pageof 14